Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Coronavirus (COVID-19)

April 7, 2020 — Baylis Medical, a Canadian-based medical device company specializing in cardiology and spine, announced ...

Home April 07, 2020
Home
An ECMO cannula being inserted into a cardiovascular patient in need of mechanical oxygenation and hemodynamic support in December 2019. The FDA just made a temporary approval to use ECMO support in COVID-19 patients during the pandemic emergency. #COVID19 #SARScov2 #coronavirus
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the ...

Home April 07, 2020
Home
COVID-19 by far was the largest driver of DAIC website traffic in March 2020. Clinicians quickly wanted to access information of the disease and its relation to cardiology as the virus rapidly spread across the United States and Europe within just the four weeks of March. #COVID19 #coronavirus #SARScov2
Feature | Dave Fornell, Editor

April 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...

Home April 06, 2020
Home
Videos | Structural Heart

Basel Ramlawi, M.D., chairman of The Heart and Vascular Center at Valley Health System in Virginia, director of the ...

Home April 03, 2020
Home
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell
Feature | Interventional Radiology | By Katie Caron

A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and ...

Home April 03, 2020
Home
News | Sudden Cardiac Arrest

April 2, 2020 — Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics ...

Home April 02, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
Blog | ACC

The novel coronavirus (COVID-19, SARS-CoVo-2) has turned normal life across the world upside down, and that was no ...

Home April 01, 2020
Home
Videos | Structural Heart

A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line,  Baylor Scott ...

Home April 01, 2020
Home
News | Coronavirus (COVID-19)

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a collaboration ...

Home March 31, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...

Home March 30, 2020
Home
News | Coronavirus (COVID-19)

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what is ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

Home March 30, 2020
Home
PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology

March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...

Home March 30, 2020
Home
Subscribe Now